{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T09:47:09Z","timestamp":1767260829723,"version":"3.44.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001843","name":"Science and Engineering Research Board","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.ijbiomac.2019.11.089","type":"journal-article","created":{"date-parts":[[2019,11,15]],"date-time":"2019-11-15T02:14:39Z","timestamp":1573784079000},"page":"1216-1225","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach"],"prefix":"10.1016","volume":"155","author":[{"given":"Aparna","family":"Nerusu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Papa Rao","family":"Vaikuntapu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh Kumar","family":"Chinthapalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Appa Rao","family":"Podile","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajagopal","family":"Subramanyam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0005","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1046\/j.1523-1755.2003.00924.x","article-title":"Review on uremic toxins: classification, concentration, and interindividual variability","volume":"63","author":"Vanholder","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0010","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1681\/ASN.2007121377","article-title":"A bench to bedside view of uremic toxins","volume":"19","author":"Vanholder","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0015","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1681\/ASN.2011121175","article-title":"Normal and pathologic concentrations of uremic toxins","volume":"23","author":"Duranton","year":"2012","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0020","doi-asserted-by":"crossref","first-page":"e111","DOI":"10.1159\/000074327","article-title":"Uremic toxins overload accelerates renal damage in a rat model of chronic renal failure","volume":"95","author":"Satoh","year":"2003","journal-title":"Nephron Exp Nephrol"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0025","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000369817","article-title":"Uremic toxins and their effects on multiple organ systems","volume":"128","author":"Lisowska-Myjak","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0030","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1093\/clinchem\/43.12.2274","article-title":"Effects of uremic toxins and fatty acids on serum protein binding of furosemide: possible mechanism of the binding defect in uremia","volume":"43","author":"Takamura","year":"1997","journal-title":"Clin. Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0035","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1046\/j.1523-1755.2000.07606.x","article-title":"The removal of uremic toxins","volume":"58","author":"Dhondt","year":"2000","journal-title":"Kidney Int."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0040","article-title":"Improved dialytic removal of protein-bound uraemic toxins with use of albumin binding competitors: an in vitro human whole blood study","volume":"6","author":"Tao","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S1665-2681(19)31602-3","article-title":"Extracorporeal liver support-albumin dialysis with the molecular adsorbent recirculating system (MARS)","volume":"10","author":"Mitzner","year":"2011","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0050","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1681\/ASN.V12suppl_1s75","article-title":"Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure","volume":"12","author":"Mitzner","year":"2001","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0055","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.jhep.2015.04.020","article-title":"Extracorporeal liver assist device to exchange albumin and remove endotoxin in acute liver failure: results of a pivotal pre-clinical study","volume":"63","author":"Lee","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0060","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1016\/j.bbagen.2013.05.005","article-title":"Albumin-drug interaction and its clinical implication","volume":"1830","author":"Yamasaki","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"Suppl. 3","key":"10.1016\/j.ijbiomac.2019.11.089_bb0065","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1478-3231.2011.02588.x","article-title":"Clearing of toxic substances: are there differences between the available liver support devices?","volume":"31","author":"Krisper","year":"2011","journal-title":"Liver Int."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0070","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0071422","article-title":"A comprehensive insight into binding of hippuric acid to human serum albumin: a study to uncover its impaired elimination through hemodialysis","volume":"8","author":"Zaidi","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0009-8981(97)00117-4","article-title":"Binding of indole-3-acetic acid to human serum albumin and competition with L-tryptophan","volume":"265","author":"Bertuzzi","year":"1997","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0080","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.colsurfb.2014.11.023","article-title":"Binding of glutathione and melatonin to human serum albumin: a comparative study","volume":"125","author":"Li","year":"2015","journal-title":"Colloids Surf B Biointerfaces"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0085","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.mam.2011.12.002","article-title":"Human serum albumin: from bench to bedside","volume":"33","author":"Fanali","year":"2012","journal-title":"Mol. Asp. Med."},{"year":"1995","series-title":"All About Albumin: Biochemistry, Genetics, and Medical Applications","author":"Peters","key":"10.1016\/j.ijbiomac.2019.11.089_bb0090"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0095","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jmb.2005.07.075","article-title":"Structural basis of the drug-binding specificity of human serum albumin","volume":"353","author":"Ghuman","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0100","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1080\/15216540500404093","article-title":"The extraordinary ligand binding properties of human serum albumin","volume":"57","author":"Fasano","year":"2005","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0105","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jphotochemrev.2012.09.001","article-title":"Binding of serum albumins with bioactive substances \u2013 nanoparticles to drugs","volume":"14","author":"Naveenraj","year":"2013","journal-title":"J. Photochem. Photobiol. C"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0110","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1248\/bpb.25.695","article-title":"Practical aspects of the ligand-binding and enzymatic properties of human serum albumin","volume":"25","author":"Kragh-Hansen","year":"2002","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0115","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/aps.2012.8","article-title":"Stereoselective binding of mexiletine and ketoprofen enantiomers with human serum albumin domains","volume":"33","author":"Shi","year":"2012","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0120","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1110\/ps.9.8.1455","article-title":"Five recombinant fragments of human serum albumin\u2014tools for the characterization of the warfarin binding site","volume":"9","author":"Dockal","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0125","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/152165499307189","article-title":"Expression of a human serum albumin fragment (consisting of subdomains IA, IB, and IIA) and a study of its properties","volume":"48","author":"Park","year":"1999","journal-title":"IUBMB Life"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0130","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1074\/jbc.275.5.3042","article-title":"Conformational transitions of the three recombinant domains of human serum albumin depending on pH","volume":"275","author":"Dockal","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0135","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1006\/prep.2000.1330","article-title":"Expression, refolding, and isotopic labeling of human serum albumin domains for NMR spectroscopy","volume":"20","author":"Mao","year":"2000","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0140","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1016\/j.bbagen.2013.01.006","article-title":"Albumin domain II mutant with high bilirubin binding affinity has a great potential as serum bilirubin excretion enhancer for hyperbilirubinemia treatment","volume":"1830","author":"Minomo","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0145","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1023\/B:PHAM.0000045248.03337.0e","article-title":"Functional analysis of recombinant human serum albumin domains for pharmaceutical applications","volume":"21","author":"Matsushita","year":"2004","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0150","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1093\/protein\/gzq054","article-title":"Tuning the serum persistence of human serum albumin domain III: diabody fusion proteins","volume":"23","author":"Kenanova","year":"2010","journal-title":"Protein Eng. Des. Sel."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0155","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ncomms1607","article-title":"Structure-based mutagenesis reveals the albumin-binding site of the neonatal fc receptor","volume":"3","author":"Andersen","year":"2012","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0160","doi-asserted-by":"crossref","first-page":"24277","DOI":"10.1074\/jbc.M113.463000","article-title":"Single-chain variable fragment albumin fusions bind the neonatal fc receptor (FcRn) in a species dependent manner: implications for in vivo half-life evaluation of albumin-fusion therapeutics","volume":"288","author":"Andersen","year":"2013","journal-title":"J. Biol. Chem."},{"year":"2010","series-title":"Invitrogen: EasySelectTM Pichia Expression Kit, Manual Part No. 25\u20130172","key":"10.1016\/j.ijbiomac.2019.11.089_bb0165"},{"year":"2010","series-title":"A Pichia Vector for Multicopy Integration and Secreted Expression Catalog No. V175\u201320","author":"Invitrogen: pPIC9K","key":"10.1016\/j.ijbiomac.2019.11.089_bb0170"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0165-022X(83)90021-0","article-title":"Removal of fatty acids from serum albumin by Lipidex 1000 chromatography","volume":"8","author":"Glatz","year":"1983","journal-title":"J. Biochem. Biophys. Methods"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00425-011-1365-4","article-title":"A root proteomics-based insight reveals dynamic regulation of root proteins under progressive drought stress and recovery in Vigna radiata (L.) Wilczek","volume":"233","author":"Sengupta","year":"2011","journal-title":"Planta"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0185","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1021\/ac900299p","article-title":"Approach for reliable evaluation of drug proteins interactions using surface plasmon resonance technology","volume":"81","author":"Sandblad","year":"2009","journal-title":"Anal. Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0190","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1021\/acsomega.7b00577","article-title":"Unraveling the stability of plasma proteins upon interaction of synthesized Androstenedione and its derivatives - a biophysical and computational approach","volume":"2","author":"Nerusu","year":"2017","journal-title":"ACS Omega"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0195","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1080\/07391102.2013.817953","article-title":"Unraveling the binding mechanism of asiatic acid with human serum albumin and its biological implications","volume":"32","author":"Gokara","year":"2014","journal-title":"J. Biomol. Struct. Dyn."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0200","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1021\/mp500051f","article-title":"Binding and molecular dynamics studies of 7-hydroxycoumarin derivatives with human serum albumin and its pharmacological importance","volume":"11","author":"Yeggoni","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S1389-1723(00)88050-0","article-title":"High-level expression of recombinant human serum albumin from the methylotrophic yeast Pichia pastoris with minimal protease production and activation","volume":"89","author":"Kobayashi","year":"2000","journal-title":"J. Biosci. Bioeng."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0210","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.pep.2013.05.002","article-title":"Construction and characterization of a potent, long-lasting recombinant human serum albumin-interferon \u03b11 fusion protein expressed in Pichia pastoris","volume":"90","author":"Tian","year":"2013","journal-title":"Protein Expr. Purif."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.bbapap.2005.06.005","article-title":"How to study proteins by circular dichroism","volume":"1751","author":"Kelly","year":"2005","journal-title":"BBA. Proteins and proteomics."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0220","doi-asserted-by":"crossref","first-page":"29303","DOI":"10.1074\/jbc.274.41.29303","article-title":"The three recombinant domains of human serum albumin. Structural characterization and ligand binding properties","volume":"274","author":"Dockal","year":"1999","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0225","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1002\/bip.22096","article-title":"About the structural role of disulfide bridges in serum albumins: evidence from protein simulated unfolding","volume":"97","author":"Paris","year":"2012","journal-title":"Biopolymers"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0230","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/abio.2001.5314","article-title":"High-resolution and high-throughput protocols for measuring drug\/human serum albumin interactions using BIACORE","volume":"296","author":"Rich","year":"2001","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0235","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1021\/jm991174y","article-title":"Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels","volume":"43","author":"Frostell-Karlsson","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0240","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1128\/AAC.00971-08","article-title":"Use of a surface plasmon resonance method to investigate antibiotic and plasma protein interactions","volume":"53","author":"Ban\u00e8res-Roquet","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0245","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/737289","article-title":"Biomolecular interaction study of cyclolinopeptide a with human serum albumin","volume":"2010","author":"Rempel","year":"2010","journal-title":"J. Biomed. Biotechnol."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0250","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jf504811x","article-title":"Kinetic interactions between cyclolinopeptides and immobilized human serum albumin by surface plasmon resonance","volume":"63","author":"Shim","year":"2015","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0255","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jpba.2016.01.051","article-title":"Surface plasmon resonance and circular dichroism characterization of cucurbitacins binding to serum albumins for early pharmacokinetic profiling","volume":"122","author":"Fabini","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0260","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1248\/bpb.18.1755","article-title":"Characterization of binding site of uremic toxins on human serum albumin","volume":"18","author":"Sakai","year":"1995","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0265","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/358209a0","article-title":"Atomic structure and chemistry of human serum albumin","volume":"358","author":"He","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2019.11.089_bb0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2017.09.018","article-title":"Using binding competitors of albumin to promote the removal of protein-bound uremic toxins in hemodialysis: Hope or pipe dream?","volume":"144","author":"Florens","year":"2018","journal-title":"Biochimie"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019363913?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813019363913?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T08:14:05Z","timestamp":1758874445000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813019363913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":54,"alternative-id":["S0141813019363913"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.11.089","relation":{},"ISSN":["0141-8130"],"issn-type":[{"type":"print","value":"0141-8130"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Truncated domains of human serum albumin improves the binding efficiency of uremic toxins: A surface plasmon resonance and computational approach","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2019.11.089","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}